Join us on Thursday, April 16, 2026, for the next program in our Antitrust Health Horizons webinar series focused on how life sciences and healthcare companies should navigate a rapidly evolving HSR landscape—and what to do now as premerger notification requirements continue to shift. 

HSR premerger notification requirements remain in flux. While the prior HSR reporting form is currently back in effect, the 2025 Updated Form, its subsequent vacatur and appeal, and the agencies’ recent request for public comments on the effectiveness of the Updated Form all point in the same direction: more upfront disclosure, more need for strategic antitrust advice, and more scrutiny during the HSR period. Whether the 2025 Updated Form returns, or a revised version replaces it, companies should expect continued pressure on deal timing, preparation, and internal coordination.  

Drawing on our team’s recent experience with filings prepared under the 2025 Updated Form, this session will provide practical, real-world guidance for in-house counsel planning transactions amid the uncertainty. We will focus on how to prepare efficiently, manage risk, and avoid surprises.

Featuring Margaret H. Campbell, Deputy General Counsel, RWJBarnabas Health, who will share an in-house perspective on preparing for HSR compliance amid evolving requirements. Margaret will be joined by Baker Botts Partner Jody Boudreault and Senior Associate Rachel Rasp who will discuss key rule changes, lessons learned from early filings and practical considerations that can make a meaningful difference.

Topics Include:

• Recent and anticipated changes in HSR filing requirements
• Strategic implications of expanded disclosure obligations
• Timing and planning in an uncertain regulatory environment
• Practical advice for in-house counsel

As antitrust agencies continue to focus on healthcare, pharmaceuticals, and medical device transactions, thorough HSR preparation is more critical than ever for successful deal execution.

Register: HSR Rules in Transition: Practical Guidance for Healthcare and Life Sciences Transactions. We look forward to having you join us!

Antitrust Health Horizons is a webinar series covering the latest competition and antitrust developments in the life sciences and healthcare sectors.

THURSDAY, April 16, 2026

• 8:00 a.m. – 09:00 a.m. (PT)
• 10:00 a.m. – 11:00 a.m. (CT)
• 11:00 a.m. – 12:00 p.m. (ET)
• 5:00 p.m. – 6:00 p.m. (CET)

ANTICIPATED CLE: TBD

• Program content is appropriate for newly admitted and experienced lawyers.

ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm whose lawyers practice throughout a network of offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the energy, technology and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.